

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of B cell receptor signaling pathway (GO:0050855) | 6.08442341 |
| 2 | cytidine deamination (GO:0009972) | 5.99489450 |
| 3 | cytidine metabolic process (GO:0046087) | 5.99489450 |
| 4 | cytidine catabolic process (GO:0006216) | 5.99489450 |
| 5 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 5.98021866 |
| 6 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 5.87207483 |
| 7 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 5.81104322 |
| 8 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.78148617 |
| 9 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 5.32755312 |
| 10 | DNA deamination (GO:0045006) | 5.28823748 |
| 11 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 5.26008032 |
| 12 | positive thymic T cell selection (GO:0045059) | 5.20286878 |
| 13 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 5.19171183 |
| 14 | regulation of natural killer cell mediated immunity (GO:0002715) | 5.19171183 |
| 15 | actin nucleation (GO:0045010) | 4.95914431 |
| 16 | positive T cell selection (GO:0043368) | 4.83054066 |
| 17 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.80275951 |
| 18 | cellular response to interleukin-15 (GO:0071350) | 4.59461911 |
| 19 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.49526959 |
| 20 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 4.40584475 |
| 21 | cytolysis (GO:0019835) | 4.27118609 |
| 22 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.20543271 |
| 23 | negative T cell selection (GO:0043383) | 4.20359180 |
| 24 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.11105562 |
| 25 | T cell migration (GO:0072678) | 4.08454946 |
| 26 | positive regulation of calcium-mediated signaling (GO:0050850) | 4.07772139 |
| 27 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.95488452 |
| 28 | iron-sulfur cluster assembly (GO:0016226) | 3.87369448 |
| 29 | metallo-sulfur cluster assembly (GO:0031163) | 3.87369448 |
| 30 | thymic T cell selection (GO:0045061) | 3.86873856 |
| 31 | negative regulation of T cell apoptotic process (GO:0070233) | 3.84397872 |
| 32 | positive regulation of cell killing (GO:0031343) | 3.81774134 |
| 33 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.79682543 |
| 34 | positive regulation of B cell differentiation (GO:0045579) | 3.79552830 |
| 35 | sequestering of actin monomers (GO:0042989) | 3.78617454 |
| 36 | negative regulation of oxidoreductase activity (GO:0051354) | 3.74351494 |
| 37 | negative thymic T cell selection (GO:0045060) | 3.73282910 |
| 38 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.72523362 |
| 39 | regulation of RIG-I signaling pathway (GO:0039535) | 3.70098925 |
| 40 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.61589847 |
| 41 | deoxyribonucleoside diphosphate metabolic process (GO:0009186) | 3.61384900 |
| 42 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 3.59368636 |
| 43 | regulation of activation of Janus kinase activity (GO:0010533) | 3.56485893 |
| 44 | negative regulation of viral genome replication (GO:0045071) | 3.55696500 |
| 45 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.51217375 |
| 46 | T cell selection (GO:0045058) | 3.50633794 |
| 47 | mast cell degranulation (GO:0043303) | 3.48321494 |
| 48 | mast cell activation involved in immune response (GO:0002279) | 3.48321494 |
| 49 | respiratory burst (GO:0045730) | 3.48272563 |
| 50 | negative regulation of stress fiber assembly (GO:0051497) | 3.48204869 |
| 51 | T cell receptor signaling pathway (GO:0050852) | 3.46873112 |
| 52 | regulation of cell killing (GO:0031341) | 3.46204792 |
| 53 | response to interleukin-15 (GO:0070672) | 3.45317751 |
| 54 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.44944902 |
| 55 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.43522396 |
| 56 | protein maturation by protein folding (GO:0022417) | 3.39908540 |
| 57 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.39141690 |
| 58 | deoxyribonucleotide catabolic process (GO:0009264) | 3.38896812 |
| 59 | ribosomal small subunit assembly (GO:0000028) | 3.36837949 |
| 60 | response to interferon-beta (GO:0035456) | 3.36640590 |
| 61 | regulation of regulatory T cell differentiation (GO:0045589) | 3.34817929 |
| 62 | positive regulation of lamellipodium assembly (GO:0010592) | 3.32535954 |
| 63 | positive regulation of T cell apoptotic process (GO:0070234) | 3.30704958 |
| 64 | deoxyribose phosphate catabolic process (GO:0046386) | 3.30180656 |
| 65 | regulation of gamma-delta T cell activation (GO:0046643) | 3.28009021 |
| 66 | natural killer cell activation (GO:0030101) | 3.26965197 |
| 67 | purine deoxyribonucleotide metabolic process (GO:0009151) | 3.26711395 |
| 68 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.26422868 |
| 69 | mast cell activation (GO:0045576) | 3.23460238 |
| 70 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.23351900 |
| 71 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.23351900 |
| 72 | T cell costimulation (GO:0031295) | 3.22087703 |
| 73 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 3.18459706 |
| 74 | lymphocyte costimulation (GO:0031294) | 3.18160787 |
| 75 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.10998122 |
| 76 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.09163864 |
| 77 | regulation of T cell apoptotic process (GO:0070232) | 3.08806513 |
| 78 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 3.08608185 |
| 79 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 3.08086920 |
| 80 | positive regulation of tolerance induction (GO:0002645) | 3.07793581 |
| 81 | macrophage chemotaxis (GO:0048246) | 3.07745874 |
| 82 | regulation of T cell tolerance induction (GO:0002664) | 3.07478314 |
| 83 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.07121033 |
| 84 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.06188165 |
| 85 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.04990547 |
| 86 | regulation of calcium-mediated signaling (GO:0050848) | 3.03270217 |
| 87 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.01401738 |
| 88 | positive regulation of granulocyte differentiation (GO:0030854) | 3.01077936 |
| 89 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.95566229 |
| 90 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.95566229 |
| 91 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.95566229 |
| 92 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.94773324 |
| 93 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.94773324 |
| 94 | immunoglobulin mediated immune response (GO:0016064) | 2.94197220 |
| 95 | deoxyribose phosphate metabolic process (GO:0019692) | 2.93776249 |
| 96 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.92765691 |
| 97 | negative regulation of monooxygenase activity (GO:0032769) | 2.91652527 |
| 98 | regulation of B cell differentiation (GO:0045577) | 2.90983608 |
| 99 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.90317159 |
| 100 | positive regulation of defense response to virus by host (GO:0002230) | 2.88731707 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.62294988 |
| 2 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.31903681 |
| 3 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 4.24014736 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.18935891 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.82841784 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.65798197 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.29837683 |
| 8 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 3.19108085 |
| 9 | MYB_26560356_Chip-Seq_TH2_Human | 3.02791823 |
| 10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.81853302 |
| 11 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.77578760 |
| 12 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.71105002 |
| 13 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.64335731 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.59887369 |
| 15 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.44749971 |
| 16 | UTX_26944678_Chip-Seq_JUKART_Human | 2.44247736 |
| 17 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.36405936 |
| 18 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.23121814 |
| 19 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.19616839 |
| 20 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.18881465 |
| 21 | MYB_26560356_Chip-Seq_TH1_Human | 2.18339711 |
| 22 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.10738022 |
| 23 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.94751639 |
| 24 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.93731558 |
| 25 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.87639405 |
| 26 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.87533017 |
| 27 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.85264250 |
| 28 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.84815349 |
| 29 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.82674511 |
| 30 | MAF_26560356_Chip-Seq_TH1_Human | 1.81063172 |
| 31 | MAF_26560356_Chip-Seq_TH2_Human | 1.77153347 |
| 32 | GATA3_26560356_Chip-Seq_TH2_Human | 1.75947200 |
| 33 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.64609843 |
| 34 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.64414223 |
| 35 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.60994686 |
| 36 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.60286671 |
| 37 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.54632346 |
| 38 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.54549244 |
| 39 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.50044112 |
| 40 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.48788827 |
| 41 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.47189393 |
| 42 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39825896 |
| 43 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.38175311 |
| 44 | P300_27268052_Chip-Seq_Bcells_Human | 1.37248039 |
| 45 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.34199291 |
| 46 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.32704142 |
| 47 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.31128011 |
| 48 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.30951276 |
| 49 | SA1_27219007_Chip-Seq_Bcells_Human | 1.28682792 |
| 50 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.28141745 |
| 51 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.25736038 |
| 52 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.25728449 |
| 53 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.22180169 |
| 54 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.19938591 |
| 55 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.17391482 |
| 56 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.17321374 |
| 57 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.15673971 |
| 58 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.15527214 |
| 59 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.15174883 |
| 60 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.14709809 |
| 61 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.13849058 |
| 62 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.13152957 |
| 63 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.12464822 |
| 64 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.11696867 |
| 65 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.10690996 |
| 66 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.03723089 |
| 67 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.03206554 |
| 68 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.02418323 |
| 69 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02030449 |
| 70 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.01380186 |
| 71 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.01119274 |
| 72 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.00769328 |
| 73 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.99553353 |
| 74 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.95661919 |
| 75 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.95348313 |
| 76 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.95341439 |
| 77 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.95011009 |
| 78 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.94170179 |
| 79 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.93900796 |
| 80 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.93831713 |
| 81 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.92623050 |
| 82 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.92583132 |
| 83 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.91442759 |
| 84 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.91235028 |
| 85 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.91070187 |
| 86 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90389647 |
| 87 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.89977401 |
| 88 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.89771542 |
| 89 | LDB1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.87581398 |
| 90 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.87064844 |
| 91 | AR_20517297_ChIP-Seq_VCAP_Human | 0.86678673 |
| 92 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.86411528 |
| 93 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.85346607 |
| 94 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.84315810 |
| 95 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83535919 |
| 96 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.83125195 |
| 97 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.82173036 |
| 98 | VDR_22108803_ChIP-Seq_LS180_Human | 0.82005961 |
| 99 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.81752709 |
| 100 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.81083236 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 6.67270317 |
| 2 | MP0005451_abnormal_body_composition | 5.48922539 |
| 3 | MP0003763_abnormal_thymus_physiology | 3.87068169 |
| 4 | MP0009785_altered_susceptibility_to | 3.44146269 |
| 5 | MP0001835_abnormal_antigen_presentation | 3.23628795 |
| 6 | MP0001873_stomach_inflammation | 3.13674347 |
| 7 | MP0002638_abnormal_pupillary_reflex | 2.73538640 |
| 8 | MP0005025_abnormal_response_to | 2.62421889 |
| 9 | MP0001800_abnormal_humoral_immune | 2.45722174 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.44341374 |
| 11 | MP0002166_altered_tumor_susceptibility | 2.43110858 |
| 12 | MP0002420_abnormal_adaptive_immunity | 2.38240723 |
| 13 | MP0001819_abnormal_immune_cell | 2.30066011 |
| 14 | MP0009333_abnormal_splenocyte_physiolog | 2.29845778 |
| 15 | MP0002723_abnormal_immune_serum | 2.27690516 |
| 16 | MP0005387_immune_system_phenotype | 2.20012090 |
| 17 | MP0001790_abnormal_immune_system | 2.20012090 |
| 18 | MP0010155_abnormal_intestine_physiology | 2.17326540 |
| 19 | MP0002148_abnormal_hypersensitivity_rea | 2.04936177 |
| 20 | MP0005645_abnormal_hypothalamus_physiol | 2.01757028 |
| 21 | MP0003866_abnormal_defecation | 2.00364233 |
| 22 | MP0002452_abnormal_antigen_presenting | 1.99146822 |
| 23 | MP0000685_abnormal_immune_system | 1.97163924 |
| 24 | MP0002398_abnormal_bone_marrow | 1.92494629 |
| 25 | MP0002933_joint_inflammation | 1.91286261 |
| 26 | MP0000716_abnormal_immune_system | 1.84444335 |
| 27 | MP0002006_tumorigenesis | 1.82542014 |
| 28 | MP0002419_abnormal_innate_immunity | 1.73756956 |
| 29 | MP0003787_abnormal_imprinting | 1.70480847 |
| 30 | MP0002405_respiratory_system_inflammati | 1.66721948 |
| 31 | MP0001845_abnormal_inflammatory_respons | 1.63407614 |
| 32 | MP0000703_abnormal_thymus_morphology | 1.61766518 |
| 33 | MP0008875_abnormal_xenobiotic_pharmacok | 1.58551183 |
| 34 | MP0000689_abnormal_spleen_morphology | 1.55807570 |
| 35 | MP0000858_altered_metastatic_potential | 1.55562868 |
| 36 | MP0002722_abnormal_immune_system | 1.54660662 |
| 37 | MP0008260_abnormal_autophagy | 1.53164669 |
| 38 | MP0000372_irregular_coat_pigmentation | 1.45942862 |
| 39 | MP0003436_decreased_susceptibility_to | 1.45709181 |
| 40 | MP0002429_abnormal_blood_cell | 1.41281786 |
| 41 | MP0008469_abnormal_protein_level | 1.34828876 |
| 42 | MP0001905_abnormal_dopamine_level | 1.32485698 |
| 43 | MP0005075_abnormal_melanosome_morpholog | 1.32163545 |
| 44 | MP0008872_abnormal_physiological_respon | 1.30864096 |
| 45 | MP0001485_abnormal_pinna_reflex | 1.29286360 |
| 46 | MP0001764_abnormal_homeostasis | 1.28464862 |
| 47 | MP0003448_altered_tumor_morphology | 1.25630883 |
| 48 | MP0005646_abnormal_pituitary_gland | 1.25280594 |
| 49 | MP0005464_abnormal_platelet_physiology | 1.24909314 |
| 50 | MP0003724_increased_susceptibility_to | 1.24496004 |
| 51 | MP0006082_CNS_inflammation | 1.23301612 |
| 52 | MP0003878_abnormal_ear_physiology | 1.18169245 |
| 53 | MP0005377_hearing/vestibular/ear_phenot | 1.18169245 |
| 54 | MP0003283_abnormal_digestive_organ | 1.18045969 |
| 55 | MP0010386_abnormal_urinary_bladder | 1.14775569 |
| 56 | MP0004947_skin_inflammation | 1.10442485 |
| 57 | MP0000490_abnormal_crypts_of | 1.08582015 |
| 58 | MP0005166_decreased_susceptibility_to | 0.97110764 |
| 59 | MP0005551_abnormal_eye_electrophysiolog | 0.92612708 |
| 60 | MP0002019_abnormal_tumor_incidence | 0.90938663 |
| 61 | MP0009763_increased_sensitivity_to | 0.89074268 |
| 62 | MP0001533_abnormal_skeleton_physiology | 0.89064594 |
| 63 | MP0009384_cardiac_valve_regurgitation | 0.84638157 |
| 64 | MP0006036_abnormal_mitochondrial_physio | 0.84083501 |
| 65 | MP0009764_decreased_sensitivity_to | 0.81983591 |
| 66 | MP0005319_abnormal_enzyme/_coenzyme | 0.80512258 |
| 67 | MP0003183_abnormal_peptide_metabolism | 0.80463236 |
| 68 | MP0001666_abnormal_nutrient_absorption | 0.79603355 |
| 69 | MP0003806_abnormal_nucleotide_metabolis | 0.78165472 |
| 70 | MP0002102_abnormal_ear_morphology | 0.78006224 |
| 71 | MP0003075_altered_response_to | 0.76455372 |
| 72 | MP0001853_heart_inflammation | 0.76155970 |
| 73 | MP0001663_abnormal_digestive_system | 0.75357039 |
| 74 | MP0009643_abnormal_urine_homeostasis | 0.74606628 |
| 75 | MP0000639_abnormal_adrenal_gland | 0.73875191 |
| 76 | MP0001986_abnormal_taste_sensitivity | 0.73714111 |
| 77 | MP0004381_abnormal_hair_follicle | 0.72192949 |
| 78 | MP0002693_abnormal_pancreas_physiology | 0.72110801 |
| 79 | MP0003646_muscle_fatigue | 0.71394370 |
| 80 | MP0003252_abnormal_bile_duct | 0.71033667 |
| 81 | MP0003137_abnormal_impulse_conducting | 0.71025249 |
| 82 | MP0001501_abnormal_sleep_pattern | 0.70145410 |
| 83 | MP0002876_abnormal_thyroid_physiology | 0.69859241 |
| 84 | MP0004147_increased_porphyrin_level | 0.69365276 |
| 85 | MP0001919_abnormal_reproductive_system | 0.66466771 |
| 86 | MP0005410_abnormal_fertilization | 0.65138157 |
| 87 | MP0001542_abnormal_bone_strength | 0.63513765 |
| 88 | MP0003693_abnormal_embryo_hatching | 0.63147203 |
| 89 | MP0006276_abnormal_autonomic_nervous | 0.62937316 |
| 90 | MP0006035_abnormal_mitochondrial_morpho | 0.62725383 |
| 91 | MP0009697_abnormal_copulation | 0.62631745 |
| 92 | MP0001765_abnormal_ion_homeostasis | 0.61009524 |
| 93 | MP0005636_abnormal_mineral_homeostasis | 0.60856598 |
| 94 | MP0006072_abnormal_retinal_apoptosis | 0.60580854 |
| 95 | MP0002132_abnormal_respiratory_system | 0.57984291 |
| 96 | MP0008961_abnormal_basal_metabolism | 0.57507023 |
| 97 | MP0000230_abnormal_systemic_arterial | 0.56756286 |
| 98 | MP0004742_abnormal_vestibular_system | 0.54507375 |
| 99 | MP0000604_amyloidosis | 0.53835956 |
| 100 | MP0002277_abnormal_respiratory_mucosa | 0.52881235 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 6.43933830 |
| 2 | Severe combined immunodeficiency (HP:0004430) | 6.11139065 |
| 3 | Abnormality of T cell number (HP:0011839) | 5.75196285 |
| 4 | Abnormality of B cell number (HP:0010975) | 5.71006221 |
| 5 | Aplastic anemia (HP:0001915) | 5.67980160 |
| 6 | B lymphocytopenia (HP:0010976) | 5.67006330 |
| 7 | Increased IgM level (HP:0003496) | 5.61825304 |
| 8 | Combined immunodeficiency (HP:0005387) | 5.13295083 |
| 9 | IgG deficiency (HP:0004315) | 5.07370794 |
| 10 | Thyroiditis (HP:0100646) | 4.58986456 |
| 11 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.53386216 |
| 12 | Autoimmune hemolytic anemia (HP:0001890) | 4.45352792 |
| 13 | Hypoproteinemia (HP:0003075) | 4.32522566 |
| 14 | Chronic diarrhea (HP:0002028) | 4.19611815 |
| 15 | Abnormality of T cells (HP:0002843) | 3.99809637 |
| 16 | Hypoplasia of the thymus (HP:0000778) | 3.91214861 |
| 17 | Agammaglobulinemia (HP:0004432) | 3.79108470 |
| 18 | Encephalitis (HP:0002383) | 3.43152138 |
| 19 | Acute hepatic failure (HP:0006554) | 3.31997062 |
| 20 | Recurrent cutaneous fungal infections (HP:0011370) | 3.28142798 |
| 21 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.28142798 |
| 22 | Myositis (HP:0100614) | 3.24887656 |
| 23 | Pancytopenia (HP:0001876) | 3.07178589 |
| 24 | Abnormality of eosinophils (HP:0001879) | 3.07143553 |
| 25 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.05682506 |
| 26 | Lymphopenia (HP:0001888) | 3.03809005 |
| 27 | Hypergammaglobulinemia (HP:0010702) | 3.01565894 |
| 28 | Stomatitis (HP:0010280) | 2.85525975 |
| 29 | Recurrent bronchitis (HP:0002837) | 2.77477446 |
| 30 | Meningitis (HP:0001287) | 2.77093259 |
| 31 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.73941210 |
| 32 | Recurrent viral infections (HP:0004429) | 2.62356475 |
| 33 | Recurrent fungal infections (HP:0002841) | 2.61918618 |
| 34 | Cellular immunodeficiency (HP:0005374) | 2.59533085 |
| 35 | Obstructive lung disease (HP:0006536) | 2.58398805 |
| 36 | Chronic obstructive pulmonary disease (HP:0006510) | 2.58398805 |
| 37 | Abnormality of the prostate (HP:0008775) | 2.56995988 |
| 38 | Cerebral palsy (HP:0100021) | 2.55862019 |
| 39 | Autoimmune thrombocytopenia (HP:0001973) | 2.54985037 |
| 40 | Pigmentary retinal degeneration (HP:0001146) | 2.51576475 |
| 41 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.47736654 |
| 42 | Abnormality of macrophages (HP:0004311) | 2.44153280 |
| 43 | Brushfield spots (HP:0001088) | 2.42431589 |
| 44 | Lymphoma (HP:0002665) | 2.36489587 |
| 45 | Increased intramyocellular lipid droplets (HP:0012240) | 2.34556377 |
| 46 | Mitochondrial inheritance (HP:0001427) | 2.33819849 |
| 47 | Spontaneous hematomas (HP:0007420) | 2.33446514 |
| 48 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.33152166 |
| 49 | Leukocytosis (HP:0001974) | 2.28617525 |
| 50 | Granulocytopenia (HP:0001913) | 2.22786839 |
| 51 | Severe visual impairment (HP:0001141) | 2.18189535 |
| 52 | Bronchitis (HP:0012387) | 2.13290834 |
| 53 | Mediastinal lymphadenopathy (HP:0100721) | 2.11752577 |
| 54 | Oligomenorrhea (HP:0000876) | 2.10157033 |
| 55 | Decreased central vision (HP:0007663) | 2.09029267 |
| 56 | Keratoconus (HP:0000563) | 2.08152612 |
| 57 | Increased corneal curvature (HP:0100692) | 2.08152612 |
| 58 | Increased muscle lipid content (HP:0009058) | 2.07500336 |
| 59 | Erythema (HP:0010783) | 2.07310526 |
| 60 | Pustule (HP:0200039) | 2.06286736 |
| 61 | Panhypogammaglobulinemia (HP:0003139) | 2.06030715 |
| 62 | Recurrent skin infections (HP:0001581) | 2.05074722 |
| 63 | Joint swelling (HP:0001386) | 2.02959050 |
| 64 | Alkalosis (HP:0001948) | 2.02788617 |
| 65 | Increased hepatocellular lipid droplets (HP:0006565) | 2.02688695 |
| 66 | Congenital stationary night blindness (HP:0007642) | 2.01087399 |
| 67 | Skin rash (HP:0000988) | 1.97175027 |
| 68 | Neutropenia (HP:0001875) | 1.94760289 |
| 69 | Pulmonary infiltrates (HP:0002113) | 1.94175607 |
| 70 | Keratoconjunctivitis sicca (HP:0001097) | 1.93790814 |
| 71 | Eosinophilia (HP:0001880) | 1.92563737 |
| 72 | Abnormality of the pleura (HP:0002103) | 1.92109686 |
| 73 | Biconcave vertebral bodies (HP:0004586) | 1.90735610 |
| 74 | IgM deficiency (HP:0002850) | 1.87677194 |
| 75 | Orchitis (HP:0100796) | 1.86055012 |
| 76 | Constricted visual fields (HP:0001133) | 1.85326762 |
| 77 | Attenuation of retinal blood vessels (HP:0007843) | 1.85132093 |
| 78 | Retrobulbar optic neuritis (HP:0100654) | 1.82228961 |
| 79 | Optic neuritis (HP:0100653) | 1.82228961 |
| 80 | Gastrointestinal infarctions (HP:0005244) | 1.81657667 |
| 81 | Acute necrotizing encephalopathy (HP:0006965) | 1.80375423 |
| 82 | Vasculitis (HP:0002633) | 1.80264139 |
| 83 | Glucose intolerance (HP:0000833) | 1.79979156 |
| 84 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.79877239 |
| 85 | Palpebral edema (HP:0100540) | 1.77087922 |
| 86 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.76399581 |
| 87 | Interstitial pulmonary disease (HP:0006530) | 1.75970545 |
| 88 | Abolished electroretinogram (ERG) (HP:0000550) | 1.75316336 |
| 89 | Keratoconjunctivitis (HP:0001096) | 1.74878615 |
| 90 | Purpura (HP:0000979) | 1.73909459 |
| 91 | Hemoptysis (HP:0002105) | 1.73048757 |
| 92 | 3-Methylglutaconic aciduria (HP:0003535) | 1.72134395 |
| 93 | Chronic otitis media (HP:0000389) | 1.71796215 |
| 94 | Increased IgE level (HP:0003212) | 1.71159978 |
| 95 | Recurrent otitis media (HP:0000403) | 1.70224549 |
| 96 | Abnormality of T cell physiology (HP:0011840) | 1.69965139 |
| 97 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.68996728 |
| 98 | Lipid accumulation in hepatocytes (HP:0006561) | 1.68975596 |
| 99 | Abnormality of the thymus (HP:0000777) | 1.68762103 |
| 100 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.64966061 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TESK2 | 5.37186991 |
| 2 | KDR | 5.18678725 |
| 3 | ZAK | 4.25424715 |
| 4 | TXK | 3.91861315 |
| 5 | TAOK3 | 3.55565995 |
| 6 | TLK1 | 3.23466235 |
| 7 | VRK1 | 3.19510392 |
| 8 | TESK1 | 2.84237528 |
| 9 | MAP4K1 | 2.82592275 |
| 10 | VRK2 | 2.60827839 |
| 11 | MAP3K11 | 2.54095240 |
| 12 | MAP3K12 | 2.41908386 |
| 13 | SCYL2 | 2.39184976 |
| 14 | TNK2 | 2.35687425 |
| 15 | CDK8 | 1.92431872 |
| 16 | LIMK1 | 1.86812324 |
| 17 | ITK | 1.84840983 |
| 18 | BCKDK | 1.76187866 |
| 19 | GRK7 | 1.75991861 |
| 20 | FES | 1.61719579 |
| 21 | TEC | 1.60359218 |
| 22 | ADRBK2 | 1.53144625 |
| 23 | PASK | 1.51109723 |
| 24 | MAP4K2 | 1.48521097 |
| 25 | BTK | 1.45099739 |
| 26 | SYK | 1.24033426 |
| 27 | KIT | 1.19297459 |
| 28 | ZAP70 | 1.13514117 |
| 29 | RPS6KA4 | 1.03264841 |
| 30 | TBK1 | 1.02031702 |
| 31 | MST4 | 1.01712243 |
| 32 | GRK6 | 0.99167517 |
| 33 | CSF1R | 0.99116367 |
| 34 | IKBKE | 0.92257298 |
| 35 | LCK | 0.89221681 |
| 36 | GRK1 | 0.86260529 |
| 37 | LYN | 0.85264044 |
| 38 | PRKCQ | 0.82797223 |
| 39 | MYLK | 0.82719772 |
| 40 | CSK | 0.81883583 |
| 41 | DAPK1 | 0.78420351 |
| 42 | JAK3 | 0.77260477 |
| 43 | PRKCH | 0.75970238 |
| 44 | SIK3 | 0.74973765 |
| 45 | MAP2K6 | 0.70051808 |
| 46 | MELK | 0.68885621 |
| 47 | NEK1 | 0.63291583 |
| 48 | NME2 | 0.61367538 |
| 49 | PIK3CG | 0.57784779 |
| 50 | LRRK2 | 0.57720214 |
| 51 | CDK4 | 0.55005389 |
| 52 | PIM1 | 0.54273754 |
| 53 | IRAK4 | 0.54235849 |
| 54 | TGFBR2 | 0.52654755 |
| 55 | AURKA | 0.52542613 |
| 56 | CLK1 | 0.51088774 |
| 57 | NLK | 0.49659743 |
| 58 | PRKD3 | 0.49231085 |
| 59 | GRK5 | 0.48354005 |
| 60 | FYN | 0.48293351 |
| 61 | RPS6KA5 | 0.48180724 |
| 62 | TNIK | 0.46797516 |
| 63 | HCK | 0.46181898 |
| 64 | TRPM7 | 0.45640286 |
| 65 | NUAK1 | 0.45543696 |
| 66 | CDK9 | 0.41667671 |
| 67 | INSRR | 0.37784266 |
| 68 | STK10 | 0.37746701 |
| 69 | DYRK1B | 0.36485142 |
| 70 | TAF1 | 0.35691279 |
| 71 | RIPK1 | 0.35286420 |
| 72 | JAK2 | 0.33812616 |
| 73 | PRKCA | 0.33155967 |
| 74 | MARK3 | 0.32840489 |
| 75 | ERN1 | 0.32413845 |
| 76 | IGF1R | 0.32055478 |
| 77 | MAP3K7 | 0.29349680 |
| 78 | ROCK1 | 0.29176597 |
| 79 | ATR | 0.28790501 |
| 80 | CSNK1G3 | 0.27350866 |
| 81 | INSR | 0.26852542 |
| 82 | OBSCN | 0.25904605 |
| 83 | TYRO3 | 0.25804906 |
| 84 | PAK1 | 0.25758007 |
| 85 | ADRBK1 | 0.25232386 |
| 86 | IKBKB | 0.24604209 |
| 87 | PKN1 | 0.24122197 |
| 88 | PRKCD | 0.23401278 |
| 89 | PRKACA | 0.22308371 |
| 90 | MAPK13 | 0.21413117 |
| 91 | TIE1 | 0.21358289 |
| 92 | PRKD2 | 0.20630032 |
| 93 | NTRK2 | 0.19673222 |
| 94 | PIK3CA | 0.19133334 |
| 95 | CSNK2A1 | 0.18612573 |
| 96 | TYK2 | 0.17463912 |
| 97 | CSNK1A1L | 0.15806563 |
| 98 | SRC | 0.15768111 |
| 99 | CAMKK1 | 0.15547216 |
| 100 | MAPK11 | 0.15485843 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 7.32771492 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 4.23475565 |
| 3 | Antigen processing and presentation_Homo sapiens_hsa04612 | 3.12812464 |
| 4 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.92964271 |
| 5 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.82521842 |
| 6 | Parkinsons disease_Homo sapiens_hsa05012 | 2.64914494 |
| 7 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.61904195 |
| 8 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.56536543 |
| 9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.46770665 |
| 10 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.31866777 |
| 11 | Ribosome_Homo sapiens_hsa03010 | 2.23808225 |
| 12 | Homologous recombination_Homo sapiens_hsa03440 | 1.97929047 |
| 13 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.90824742 |
| 14 | Allograft rejection_Homo sapiens_hsa05330 | 1.79370965 |
| 15 | Alzheimers disease_Homo sapiens_hsa05010 | 1.67172963 |
| 16 | Malaria_Homo sapiens_hsa05144 | 1.64857245 |
| 17 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.62888529 |
| 18 | Measles_Homo sapiens_hsa05162 | 1.61233198 |
| 19 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.54063747 |
| 20 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.50803650 |
| 21 | Huntingtons disease_Homo sapiens_hsa05016 | 1.48594325 |
| 22 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.39861771 |
| 23 | RNA polymerase_Homo sapiens_hsa03020 | 1.37956612 |
| 24 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.37208709 |
| 25 | Peroxisome_Homo sapiens_hsa04146 | 1.34137261 |
| 26 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.33970509 |
| 27 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.32910903 |
| 28 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.28848528 |
| 29 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.25412653 |
| 30 | Shigellosis_Homo sapiens_hsa05131 | 1.23072233 |
| 31 | DNA replication_Homo sapiens_hsa03030 | 1.22570332 |
| 32 | Phototransduction_Homo sapiens_hsa04744 | 1.17563405 |
| 33 | Mismatch repair_Homo sapiens_hsa03430 | 1.16607111 |
| 34 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.15719653 |
| 35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.03043419 |
| 36 | Olfactory transduction_Homo sapiens_hsa04740 | 0.99002869 |
| 37 | Viral myocarditis_Homo sapiens_hsa05416 | 0.98860400 |
| 38 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.97859913 |
| 39 | Salmonella infection_Homo sapiens_hsa05132 | 0.96003915 |
| 40 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.93331836 |
| 41 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.85463800 |
| 42 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.84862490 |
| 43 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.83279816 |
| 44 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.82612392 |
| 45 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.80516951 |
| 46 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.78686421 |
| 47 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.77443691 |
| 48 | Purine metabolism_Homo sapiens_hsa00230 | 0.76474473 |
| 49 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.75921273 |
| 50 | Base excision repair_Homo sapiens_hsa03410 | 0.75693751 |
| 51 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.75471024 |
| 52 | Asthma_Homo sapiens_hsa05310 | 0.75315999 |
| 53 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.75229973 |
| 54 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.74168485 |
| 55 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.73869454 |
| 56 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.73325094 |
| 57 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.71255528 |
| 58 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.68715889 |
| 59 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.66928971 |
| 60 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.60434335 |
| 61 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.59550789 |
| 62 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.59495675 |
| 63 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.58882940 |
| 64 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.52151550 |
| 65 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.49753444 |
| 66 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.49325788 |
| 67 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.47893783 |
| 68 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.46324298 |
| 69 | Leishmaniasis_Homo sapiens_hsa05140 | 0.45605242 |
| 70 | RNA degradation_Homo sapiens_hsa03018 | 0.45366570 |
| 71 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.45115458 |
| 72 | HTLV-I infection_Homo sapiens_hsa05166 | 0.40197436 |
| 73 | Retinol metabolism_Homo sapiens_hsa00830 | 0.40029297 |
| 74 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.39523236 |
| 75 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.37343378 |
| 76 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.35423789 |
| 77 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.33884213 |
| 78 | Platelet activation_Homo sapiens_hsa04611 | 0.33489365 |
| 79 | Endocytosis_Homo sapiens_hsa04144 | 0.32001945 |
| 80 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.31736415 |
| 81 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.30198678 |
| 82 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.30071370 |
| 83 | Taste transduction_Homo sapiens_hsa04742 | 0.29782264 |
| 84 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.28816949 |
| 85 | Tuberculosis_Homo sapiens_hsa05152 | 0.27870819 |
| 86 | Pertussis_Homo sapiens_hsa05133 | 0.27754894 |
| 87 | Influenza A_Homo sapiens_hsa05164 | 0.26712803 |
| 88 | Metabolic pathways_Homo sapiens_hsa01100 | 0.26319575 |
| 89 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.25850308 |
| 90 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.23612190 |
| 91 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.23496741 |
| 92 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.23405744 |
| 93 | Sulfur relay system_Homo sapiens_hsa04122 | 0.23073114 |
| 94 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.23019100 |
| 95 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.22275265 |
| 96 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.21781103 |
| 97 | Apoptosis_Homo sapiens_hsa04210 | 0.20132713 |
| 98 | Legionellosis_Homo sapiens_hsa05134 | 0.19494531 |
| 99 | Alcoholism_Homo sapiens_hsa05034 | 0.18334554 |
| 100 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.17372442 |

